ES2107375A1 - Formulaciones farmaceuticas liquidas de ebastina por via oral. - Google Patents

Formulaciones farmaceuticas liquidas de ebastina por via oral.

Info

Publication number
ES2107375A1
ES2107375A1 ES09501556A ES9501556A ES2107375A1 ES 2107375 A1 ES2107375 A1 ES 2107375A1 ES 09501556 A ES09501556 A ES 09501556A ES 9501556 A ES9501556 A ES 9501556A ES 2107375 A1 ES2107375 A1 ES 2107375A1
Authority
ES
Spain
Prior art keywords
ebastin
liquid pharmaceutical
pharmaceutical formulations
oral route
formulations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES09501556A
Other languages
English (en)
Other versions
ES2107375B1 (es
Inventor
Jose Luis Fabregas
Mauri Jacinto Moraques
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Almirall SA
Original Assignee
Laboratorios Almirall SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratorios Almirall SA filed Critical Laboratorios Almirall SA
Priority to ES9501556A priority Critical patent/ES2107375B1/es
Publication of ES2107375A1 publication Critical patent/ES2107375A1/es
Application granted granted Critical
Publication of ES2107375B1 publication Critical patent/ES2107375B1/es
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

FORMULACIONES FARMACEUTICAS LIQUIDAS DE EBASTINA POR VIA ORAL. FORMULACIONES FARMACEUTICAS LIQUIDAS DE 4 -DIFENILMETOXI -1- [3- (4-TERBUTILBENZOIL) PROPIL] PIPERIDINA, CUYA DENOMINACION COMAN ES EBASTINA, QUE CONTIENEN ACIDOS CARBOXILICOS HIDROXILADOS, TENSIOACTIVOS NO IONICOS Y POLIOLES DE CADENA MEDIA EN UNA PROPORCION COMPRENDIDA ENTRE 1:1:3:25 Y 3:10:25:500 RESPECTIVAMENTE, JUNTO CON EXCIPIENTES O DILUYENTES FARMACEUTICAMENTE ACEPTABLES. ESTAS FORMULACIONES SE UTILIZAN PARA EL TRATAMIENTO DE PROCESOS ALERGICOS COMO RINITIS, URTICARIA, DERMATITIS O CONJUNTIVITIS.
ES9501556A 1995-08-01 1995-08-01 Formulaciones farmaceuticas liquidas de ebastina por via oral. Expired - Fee Related ES2107375B1 (es)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ES9501556A ES2107375B1 (es) 1995-08-01 1995-08-01 Formulaciones farmaceuticas liquidas de ebastina por via oral.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES9501556A ES2107375B1 (es) 1995-08-01 1995-08-01 Formulaciones farmaceuticas liquidas de ebastina por via oral.

Publications (2)

Publication Number Publication Date
ES2107375A1 true ES2107375A1 (es) 1997-11-16
ES2107375B1 ES2107375B1 (es) 1998-07-01

Family

ID=8291245

Family Applications (1)

Application Number Title Priority Date Filing Date
ES9501556A Expired - Fee Related ES2107375B1 (es) 1995-08-01 1995-08-01 Formulaciones farmaceuticas liquidas de ebastina por via oral.

Country Status (1)

Country Link
ES (1) ES2107375B1 (es)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013081562A1 (en) 2011-10-13 2013-06-06 Mahmut Bilgic Oral formulations comprising ebastine

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0171331A1 (fr) * 1984-08-03 1986-02-12 Laboratoire Vaillant Defresne Nouvelle composition liquide à base de formiate de quinine
FR2624736A1 (fr) * 1987-12-16 1989-06-23 Dietlin Francois Nouvelles compositions pharmaceutiques dispersibles dans l'eau a base d'ornidazole
WO1992016210A1 (fr) * 1991-03-13 1992-10-01 Rhone-Poulenc Rorer S.A. Nouvelles compositions liquides a base de derives de la piperidine substitues en 1,4
ES2052075T3 (es) * 1989-01-23 1994-07-01 Merrell Dow Pharma Composicion farmaceutica liquida para derivados de piperidinoalcanol.
US5574045A (en) * 1995-06-06 1996-11-12 Hoechst Marion Roussel, Inc. Oral pharmaceutical composition of piperidinoalkanol compounds in solution form

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0171331A1 (fr) * 1984-08-03 1986-02-12 Laboratoire Vaillant Defresne Nouvelle composition liquide à base de formiate de quinine
FR2624736A1 (fr) * 1987-12-16 1989-06-23 Dietlin Francois Nouvelles compositions pharmaceutiques dispersibles dans l'eau a base d'ornidazole
ES2052075T3 (es) * 1989-01-23 1994-07-01 Merrell Dow Pharma Composicion farmaceutica liquida para derivados de piperidinoalcanol.
WO1992016210A1 (fr) * 1991-03-13 1992-10-01 Rhone-Poulenc Rorer S.A. Nouvelles compositions liquides a base de derives de la piperidine substitues en 1,4
US5574045A (en) * 1995-06-06 1996-11-12 Hoechst Marion Roussel, Inc. Oral pharmaceutical composition of piperidinoalkanol compounds in solution form

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013081562A1 (en) 2011-10-13 2013-06-06 Mahmut Bilgic Oral formulations comprising ebastine

Also Published As

Publication number Publication date
ES2107375B1 (es) 1998-07-01

Similar Documents

Publication Publication Date Title
MA26901A1 (fr) Nouvelle composition pharmaceutique
CA2260145A1 (en) Use of l-acetylcarnitine, l-isovalerylcarnitine, l-propionylcarnitine for increasing the levels of igf-1
DZ2420A1 (fr) Formulations nouvelles comprenant l'amoxycilline et du clavulanate et procédé pour leur préparation.
DK0927024T3 (da) Indretning og fremgangsmåde til behandling af öjensygdomme
ZA967746B (en) Treatment of tinnitus using neuroprotective agents.
NO903911D0 (no) Fremgangsmaate for fremstilling av 4-hydroksytetrahydropyran-2-on og de tilsvarende dihydroksykarboksylsyrederivater, salter og estere, deres anvendelse som legemidler, farmasoeytiske preparater og forprodukter.
ES2052065T3 (es) Formulacion dispersable.
BR9914940A (pt) Método para aperfeiçoar a farmacocinética de tipranavir
GB9305295D0 (en) Therapeutic compounds
KR0148213B1 (en) Phenyla lkan(en)oic acid and pharmaceutical composition comprising the same
IT1283225B1 (it) Ceppi di batteri, composizione farmaceutica contenente uno o piu' di tali ceppi e uso dei medesimi per la prevenzione e la terapia delle
NO973912D0 (no) Preventivt eller terapeutisk medikament for sykdommen Alzheimer
MY103210A (en) Arylpiperazinyl-alkylene-phenyl-heterocyclic compounds.
NO175307C (no) Analogifremgangsmåte for fremstilling av nye terapeutisk aktive 3,3'-ditiobis(propionsyrer)
PT790236E (pt) Pro-farmacos de 5-(2-(4-(1,2-benzisotiazol-3-il)-1-piperazinil)-etil-6-cloro-1,3-di-hidro-2h-indol-2-ona
PH31643A (en) 2-Oxidole-1-carboxamide pharmaceutical agents for the treatment of alzheimer's disease.
ES2107375A1 (es) Formulaciones farmaceuticas liquidas de ebastina por via oral.
PT1152762E (pt) Utilizacao de desoxipeganina no tratamento da demencia de alzheimer
GR3005736T3 (es)
EP0618812A4 (en) USE OF PROTEASE NEXIN-I AS ANTI-INFLAMMATORY.
DK0657431T3 (da) 4-Phenyl-3-substituerede 1,4-dihydropyridinestere med cerebral virkning.
DK47988D0 (da) Substituerede 3-phenyl-7h-thiazolooe3,2-baaoe1,2,4aatriazin-7-oner, deres fremstilling og anvendelse som laegemiddel, samt ved fremstillingen anvendelige mellemprodukter
EP1305008A4 (en) Improved forms of pharmaceutical ingredients and method for their preparation
DE58902264D1 (de) Beta-lactam-antibiotika, verfahren zu ihrer herstellung und ihre verwendung als und in arzneimitteln.
GR3018126T3 (en) 4-[(Thiophene-2-carbonyl)oxy]pyrrolidine-2-carboxylic acid, its preparation and its use as anti-inflammatory and anti-dystrophic agent.

Legal Events

Date Code Title Description
EC2A Search report published

Date of ref document: 19971116

Kind code of ref document: A1

Effective date: 19971116

PC2A Transfer of patent
FD2A Announcement of lapse in spain

Effective date: 20180806